加载中...

Marvell Technology, Inc. (MRVL) 财务分析 | 估值·财报 | 100Baggers.club

Marvell Technology, Inc.

MRVL

Marvell Technology, Inc., together with its subsidiaries, designs, develops, and sells analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers a portfolio of Ethernet solutions, including controllers, network adapters, physical transceivers, and switches; single or multiple core processors; ASIC; and printer System-on-a-Chip products and application processors. The company also provides a range of storage products comprising storage controllers for hard disk drives (HDD) and solid-state drives that support various host system interfaces consisting of serial attached SCSI (SAS), serial advanced technology attachment (SATA), peripheral component interconnect express, non-volatile memory express (NVMe), and NVMe over fabrics; and fiber channel products, including host bus adapters, and controllers for server and storage system connectivity. It has operations in the United States, China, Malaysia, the Philippines, Thailand, Singapore, India, Israel, Japan, South Korea, Taiwan, and Vietnam. Marvell Technology, Inc. was incorporated in 1995 and is headquartered in Wilmington, Delaware.

深度研究阅读完整报告

Marvell Technology美满电子(MRVL)股票深度分析 — AI全栈芯片的护城河幻觉

市场热捧的“AI小博通”，其定制芯片护城河却可能是个危险幻觉——这揭示了在超大规模客户主导的时代，看似强大的技术壁垒背后隐藏的议价权脆弱性。

加载图表中...

加载图表中...

利润瀑布图分析

加载图表中...

加载图表中...

加载图表中...

加载图表中...

现金流瀑布图

加载图表中...

流入

流出

小计

起止点

加载图表中...

📊 估值

关键估值指标

EV/EBITDA (TTM)

i

Enterprise Value, EBITDA and Ratio

EV/EBIT (TTM)

i

Enterprise Value, EBIT and Ratio

EV/Sales (TTM)

i

Enterprise Value, Revenue and Ratio

P/E Ratio (TTM)

i

Market Cap, Net Income and Ratio

P/B Ratio (Quarterly)

i

Market Cap, Book Value and Ratio

FCF Yield (TTM)

i

FCF, Enterprise Value and Yield

PR Profit Ratio (PPM)

i

PE Ratio, ROE and Profit Ratio (PR = PE / ROE)

📈 成长

营收、盈利和每股成长指标

Revenue (Quarterly)

i

Quarterly Revenue

Revenue/Share (Quarterly)

i

Revenue Per Share

Net Income (Quarterly)

i

Quarterly Net Income

EPS (Quarterly)

i

Earnings Per Share

Gross Profit/Share (Quarterly)

i

Gross Profit Per Share

OCF/Share (Quarterly)

i

Operating Cash Flow Per Share

FCF/Share (Quarterly)

i

Free Cash Flow Per Share

Operating Leverage (YoY)

i

Change in Operating Income / Change in Revenue

💰 盈利

利润率和净资产收益率

Gross Margin (TTM)

i

Revenue, Gross Profit and Gross Margin

Operating Margin (TTM)

i

Revenue, Operating Income and Operating Margin

Net Profit Margin (TTM)

i

Revenue, Net Income and Net Profit Margin

ROE (TTM)

i

Equity, Net Income and Return on Equity

ROA (TTM)

i

Assets, Net Income and Return on Assets

ROTCE - Return on Tangible Common Equity (TTM)

i

Net Income, Tangible Common Equity and ROTCE

OCF Margin (TTM)

i

Revenue, Operating Cash Flow and OCF Margin

FCF Margin (TTM)

i

Revenue, Free Cash Flow and FCF Margin

💵 现金质量

现金流质量和转换指标

OCF/NI Ratio (TTM)

i

Operating Cash Flow, Net Income and Ratio

FCF/NI Ratio (TTM)

i

Free Cash Flow, Net Income and Ratio

OCF/Capex (TTM)

i

Operating Cash Flow, Capex and Coverage Ratio

OCF/SBC (TTM)

i

Operating Cash Flow, SBC and Coverage Ratio

🛡️ 财务韧性

债务、流动性和财务健康度

Debt/Equity (quarterly)

i

Total Debt, Total Equity and Debt/Equity Ratio

EBITDA/Net Debt (TTM)

i

EBITDA, Net Debt and Coverage Ratio

Interest Coverage (TTM)

i

EBIT, Interest Expense and Coverage Ratio

Current Ratio (quarterly)

i

Current Assets, Current Liabilities and Current Ratio

Quick Ratio (quarterly)

i

Quick Assets, Current Liabilities and Quick Ratio

Altman Z-Score

i

Financial Distress Prediction Model

⚙️ 运营与资本效率

资产利用率、营运资本、ROIC和资本效率

ROIC (TTM)

i

NOPAT, Invested Capital and Return on Invested Capital

ROCE - Return on Capital Employed (TTM)

i

EBIT, Capital Employed and Return on Capital Employed

Asset Turnover (TTM)

i

Revenue, Total Assets and Turnover Ratio

CapEx/Depreciation - Investment Intensity (TTM)

i

CapEx, Depreciation and Ratio (>1=Expansion, <1=Contraction)

R&D/Gross Profit - R&D Intensity (TTM)

i

R&D Expenses, Gross Profit and Ratio

SG&A/Revenue - SG&A Efficiency (TTM)

i

SG&A Expenses, Revenue and Ratio

Cash Conversion Cycle (TTM)

i

DSO + DIO - DPO (in days)

DSO - Days Sales Outstanding (TTM)

i

Average Receivables and Days Sales Outstanding

DIO - Days Inventory Outstanding (TTM)

i

Average Inventory and Days Inventory Outstanding

DPO - Days Payables Outstanding (TTM)

i

Average Payables and Days Payables Outstanding

Goodwill/Assets (Quarterly)

i

Goodwill as % of Total Assets

🎁 股东回报

股息、股票回购、稀释和内部人交易活动

Dividend Yield (TTM)

i

Dividend Per Share, Share Price and Dividend Yield

Buyback Yield (TTM)

i

Net Buyback and Buyback Yield

Buyback Yield (3 Years)

i

Net Buyback 3Y and Buyback Yield 3Y

Dilution Rate (1 Year)

i

Current Shares, 1Y Ago Shares and Dilution Rate

Dilution Rate (3 Years)

i

Current Shares, 3Y Ago Shares and Dilution Rate

SBC Offset Rate (TTM)

i

Buyback / Stock-Based Comp and SBC Ratio

Insider Activity Rate (TTM)

i

Insider Net Buying and Activity Rate

P

盈利能力指标

Gross Profit Margini毛利率

52.15%

毛利润 = $1.26B

营业收入 = $2.42B

Operating Profit Margini营业利润率

14.04%

营业利润 = $0.34B

营业收入 = $2.42B

EBITDA MarginiEBITDA利润率

27.74%

EBITDA = $0.67B

营业收入 = $2.42B

EBIT MarginiEBIT利润率

14.48%

EBIT = $0.08B

营业收入 = $2.42B

Net Profit Margini净利率

1.43%

净利润 = $0.03B

营业收入 = $2.42B

Pretax Profit Margini税前利润率

3.45%

税前利润 = $0.08B

营业收入 = $2.42B

E

运营效率指标

Interest Coveragei利息保障倍数

15.72x

EBIT (TTM) = $3.32B

利息费用 (TTM) = $0.21B

-1.5x

0.5x

14.8x

15.2x

15.7x

SG&A / Revenuei销管费率

10.69%

销售及管理费用 = $0.26B

营业收入 = $2.42B

R&D / Revenuei研发占比

26.98%

研发费用 = $0.65B

营业收入 = $2.42B

R

回报率指标 (TTM)

ROAi总资产回报率

10.72%

净利润 = $2.53B

平均总资产 = $23.57B

ROEi净资产收益率

15.97%

净利润 = $2.53B

平均股东权益 = $15.82B

ROICi投入资本回报率

6.71%

NOPAT (TTM) = $1.21B

平均投入资本 = $18.11B

(NOPAT = 营业利润 × (1 - 有效税率))

(平均投入资本 = (本期IC + 去年同期IC) / 2)

Revenue Growthi营收增长率

27.57%

当期营收 = $2.42B

去年同期营收 = $1.90B

+63.3%

+57.6%

+36.8%

+22.1%

+27.6%

Operating Cash Flow/Sharei每股经营现金流

$2.30

经营现金流 = $2.06B

流通股数 = 0.89B

$1.93

$2.12

$2.17

$2.04

$2.30

综合分析

利润表项目	同比增长	当季数据	趋势
营业收入	+27.6%	$2.42B	↑
毛利	+32.4%	$1.26B, 52.15%	↑
营业利润	+25.4%	$0.34B, 14.04%	↑
EBITDA	+11.7%	$0.67B, 27.74%	↑
税前利润	-61.4%	$0.08B, 3.45%	↓
净利润	-80.6%	$0.03B, 1.43%	↓
稀释每股收益	-80.0%	0.04	↓

L

流动性指标

Current Ratioi流动比率

3.28

健康

流动资产 = $7.46B

流动负债 = $2.28B

Quick Ratioi速动比率

2.66

健康

速动资产 = $6.06B

流动负债 = $2.28B

Cash Ratioi现金比率

1.69

健康

现金及等价物 = $3.84B

流动负债 = $2.28B

Cash Ratio = (Cash + Short-term Investments) / Current Liabilities

L

杠杆指标

Debt to Equityi债务权益比

0.27

健康

总债务 = $4.96B

总权益 = $18.22B

Liabilities to Assetsi资产负债率 (总负债)

32.4%

健康

总负债 = $8.73B

总资产 = $26.94B

Equity Multiplieri权益乘数

1.48

健康

总资产 = $26.94B

总权益 = $18.22B

E

效率指标

Asset Turnoveri总资产周转率

0.37

关注

营收 (TTM) = $8.72B

平均总资产 = $23.57B

Inventory Turnoveri存货周转率

3.09

关注

营业成本 (TTM) = $4.30B

平均存货 = $1.39B

Receivables Turnoveri应收账款周转率

4.30

正常

营收 (TTM) = $8.72B

平均应收账款 = $2.03B

S

偿债能力

Interest Coveragei利息保障倍数

15.72

健康

EBIT (TTM) = $3.32B

利息费用 (TTM) = $0.21B

Net Debt to EBITDAi净债务/EBITDA

0.24

健康

净债务 = $1.12B

EBITDA (TTM) = $4.60B

Debt Service Coveragei偿债覆盖率

N/A

正常

经营现金流 (TTM) = $2.06B

债务偿付 = $0.00B

V

价值指标

Goodwill %i商誉占比

51.5%

关注

商誉 = $13.88B

总资产 = $26.94B

Working Capital Ratioi营运资本比率

0.19

正常

营运资本 = $5.19B

总资产 = $26.94B

C

现金流指标

经营现金流 TTMi

$2.06B

自由现金流 TTMi

$1.66B

FCF = OCF - CapEx

经营现金流 (TTM) = $2.06B

资本支出 (TTM) = $-0.39B

自由现金流收益率i

0.95%

关注

FCF (TTM) = $1.66B

市值 = $175.25B

经营现金流/销售比i

23.59%

健康

经营现金流 (TTM) = $2.06B

营业收入 (TTM) = $8.72B

Q

质量与覆盖指标

收益质量i

0.81x

关注

经营现金流 (TTM) = $2.06B

净利润 (TTM) = $2.53B

现金流/债务比i

0.41x

正常

经营现金流 (TTM) = $2.06B

总负债 = $4.96B

短期覆盖率i

0.90x

健康

经营现金流 (TTM) = $2.06B

流动负债 = $2.28B

资本支出覆盖率i

5.24x

健康

经营现金流 (TTM) = $2.06B

资本支出 (TTM) = $0.39B

E

效率指标

⚡ 比率按USD计算，去除汇率影响

自由/经营现金流比i

80.93%

健康

自由现金流 (TTM) = $1.66B

经营现金流 (TTM) = $2.06B

资本支出/营收比i

4.50%

健康

资本支出 (TTM) = $0.39B

营业收入 (TTM) = $8.72B

净债务/EBITDAi

0.24

健康

净债务 = $1.12B

EBITDA (TTM) = $4.60B

G

增长指标

经营现金流增长率i

91.89%

健康

当期OCF (TTM) = $0.64B

上期OCF = $0.33B

股东盈余i

$3.42B

健康

净利润 (TTM) = $2.53B

+ 折旧摊销 (TTM) = $1.28B

- 资本支出 (TTM) = $-0.39B